This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (2) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pijls, R. T. Articles by Nuijts, R. M.M.A. Search for Related Content Social Bookmarking                         What's this?

Flexible Coils with a Drug-Releasing Hydrophilic Coating: A New Platform for Controlled Delivery of Drugs to the Eye?

Centre for Biomaterials Research, Faculty of Medicine, University of Maastricht, PO Box 616, NL-6200 MD Maastricht, the Netherlands and Faculty of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands

Leo H. Koole

Centre for Biomaterials Research, Faculty of Medicine, University of Maastricht, PO Box 616, NL-6200 MD Maastricht, the Netherlands and Faculty of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands, l.koole{at}bioch.unimaas.nl

Hans H.L. Hanssen

MCTec BV, Venlo, the Netherlands

Rudy M.M.A. Nuijts

Department of Ophthalmology, Academic Hospital, Maastricht, the Netherlands

Delivery of drugs to the front-side of the eye is routinely done through eye drops. It is known that approximately 80% of each eye-drop is lost, as a result of rapid clearance of the tear fluid via the naso-lacrymal canal. Consequently, repeated administration through several droplets is usually necessary to achieve a desired effect, such as widening of the pupil prior to corneal surgery. A new ocular drug delivery device was studied. The new device is believed to provide a basis for a more convenient and efficient method for ocular drug delivery. The device is a metallic coil with a hydrophilic, drug-containing polymeric coating. The coil is placed in the conjuctival fornix (under the lower eye-lid) and the drug is slowly released by diffusion into the tear fluid. The capacity of the device could be increased by using the lumen of the coils as a depot for the drug to be released. Preliminary experiments with the new device were performed largely in vitro and in vivo. The latter experiments involved the release of a fluorescent dye and atropine (a potent mydriatic agent) in the eye of several healthy volunteers. The first results obtained with the new device indicate its potential utility. More research and development work is required to define the optimal design of the coil in order to minimize the risk of irritation. Furthermore, the parameters that define the kinetics of the intraocular drug release must be defined and optimized with respect to the exact application.

Key Words: drug delivery • hydrophilic coatings • antibiotics release • mydriasis

Journal of Bioactive and Compatible Polymers, Vol. 19, No. 4, 267-285 (2004)
DOI: 10.1177/0883911504045175


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?